Recurrent Miscarriage and IVF: Testing, PGT, and Treatment Planning

Recurrent miscarriage can be emotionally difficult, but a structured evaluation often identifies treatable factors and helps couples plan the next pregnancy attempt more safely. IVF with embryo testing may be helpful in selected cases, especially when chromosomal factors are suspected, but it is only one part of a personalized treatment plan.

Overview

Recurrent miscarriage, also called recurrent pregnancy loss, usually means two or more pregnancy losses. Some clinics begin evaluation after two losses, while others may use three losses depending on age, medical history and local guidelines. For patients considering fertility care, recurrent miscarriage and IVF planning should begin with a careful search for possible causes rather than moving directly to a standard IVF cycle.

Many miscarriages happen because an embryo has an abnormal number of chromosomes. This is more common as maternal age increases, but it can occur at any age. In other cases, miscarriage may be linked to uterine shape, fibroids or adhesions, thyroid disease, diabetes, antiphospholipid syndrome, inherited chromosome rearrangements in one parent, sperm factors or unexplained reasons.

IVF may help in selected situations because it allows embryos to be created in the laboratory, monitored during early development and, when appropriate, tested before transfer. However, IVF is not a universal solution for miscarriage. A patient-centered plan usually combines testing, counseling, embryo strategy and preparation of the uterus and general health before pregnancy.

Symptoms and Pregnancy Loss Patterns

Symptoms of miscarriage can include vaginal bleeding, pelvic cramping, loss of pregnancy symptoms, passage of tissue or a pregnancy that stops developing before symptoms appear. Some losses are detected only during ultrasound when the embryo has no heartbeat or the pregnancy has not developed as expected. Any bleeding in pregnancy should be discussed with a clinician, although bleeding does not always mean that a miscarriage will occur.

The timing and pattern of losses can guide the evaluation. Very early losses may suggest embryo chromosome problems, implantation factors or hormonal issues. Losses after a heartbeat has been seen, or losses in the second trimester, may lead doctors to look more closely at uterine anatomy, cervical factors, clotting-related conditions, infection in selected cases or maternal medical problems.

Doctors may also review whether losses occurred naturally, after intrauterine insemination, or after IVF. If miscarriage happens after transfer of a tested embryo, the next steps may focus more on uterine, immune, endocrine, metabolic and technical factors. If losses happen after untested embryos, embryo chromosome status may be part of the discussion.

Causes and Risk Factors

The most common cause of sporadic miscarriage is a random chromosomal error in the embryo. In recurrent miscarriage, chromosomal factors are still important, but doctors also consider whether one partner carries a balanced translocation or another chromosome rearrangement. A carrier may be healthy but produce eggs or sperm that can form embryos with missing or extra genetic material.

Uterine factors can also contribute. A septate uterus, significant fibroids that distort the cavity, intrauterine adhesions, endometrial polyps or congenital uterine differences may affect implantation or pregnancy growth. In some patients, hysteroscopy, saline ultrasound or specialized imaging helps clarify whether treatment is needed before another pregnancy attempt.

Medical and hormonal conditions may influence miscarriage risk, especially if they are not well controlled. These include thyroid disease, poorly controlled diabetes, obesity, polycystic ovary syndrome, high prolactin levels and some autoimmune conditions. Antiphospholipid syndrome is one well-established immune-related cause of recurrent pregnancy loss and has specific testing and treatment pathways.

Male factors are increasingly considered in recurrent miscarriage. Standard semen analysis is useful, but it may not capture all sperm-related issues. In selected couples, sperm DNA fragmentation testing, review of lifestyle exposures, varicocele assessment or use of laboratory techniques such as ICSI may be discussed, although these decisions should be individualized.

Recommended Testing After Recurrent Miscarriage

A recurrent miscarriage evaluation begins with a detailed history. The fertility specialist reviews the number and timing of losses, ultrasound findings, prior genetic results, menstrual history, medical conditions, medications, surgeries, family history and lifestyle factors. If products of conception from a miscarriage were tested, those results can be very helpful for deciding whether embryo chromosome problems are likely to be recurring.

Common tests may include parental karyotypes, uterine cavity assessment, thyroid-stimulating hormone, diabetes screening, prolactin when indicated and antiphospholipid antibody testing. Depending on the history, doctors may add ovarian reserve tests, progesterone assessment in selected situations, infection evaluation, autoimmune review or thrombophilia testing. Not every patient needs every test, and broad panels without a clear reason can create confusion.

For patients with difficulty conceiving as well as miscarrying, a complete fertility work-up is important. This may include ovulation assessment, tubal evaluation, semen analysis and ovarian reserve testing as part of a broader female infertility assessment. The goal is to understand both why pregnancy is not continuing and whether conception itself requires support.

Genetic counseling may be recommended if a parental chromosome rearrangement is found, if multiple miscarriages have abnormal genetic results, or if there is a family history of genetic disease. Counseling helps couples understand recurrence risk, embryo testing options, natural conception choices, donor gametes or prenatal diagnostic testing in a future pregnancy.

IVF, PGT-A and Embryo Testing

IVF can be used after recurrent miscarriage for several reasons. It allows eggs and sperm to be combined outside the body, embryos to be cultured, and embryo transfer to be timed carefully. In some cases, IVF treatment is considered when recurrent miscarriage occurs together with infertility, advanced maternal age, tubal disease, severe male-factor infertility or a known parental chromosome rearrangement.

Preimplantation genetic testing for aneuploidy, known as PGT-A, screens embryos for missing or extra chromosomes before transfer. The aim is to select embryos that are more likely to be chromosomally balanced. This may reduce the chance of miscarriage related to embryo aneuploidy, particularly for some older patients or couples with repeated losses due to chromosomal errors.

PGT-A has limitations. It requires embryo biopsy, laboratory analysis and embryo freezing in many programs. Results may include euploid embryos, aneuploid embryos or mosaic embryos, and mosaic findings require careful counseling. PGT-A does not test for every genetic condition, does not guarantee implantation or live birth, and cannot prevent miscarriage caused by uterine, hormonal, immune or medical factors.

Another type of testing, PGT-SR, may be used when a parent carries a structural chromosome rearrangement such as a balanced translocation. PGT-M may be used for a known single-gene condition. The choice between no testing, PGT-A, PGT-SR or PGT-M should be based on the couple’s history, age, embryo number, genetic findings and values.

Treatment Planning Before the Next Pregnancy

Treatment planning is most effective when it targets identified causes. If a uterine septum, significant cavity-distorting fibroid, polyp or adhesions are found, a fertility specialist may discuss hysteroscopic or surgical correction. If thyroid disease, diabetes or high prolactin is present, medical optimization before conception can improve pregnancy readiness.

For antiphospholipid syndrome, treatment may include pregnancy-safe blood-thinning medication and low-dose aspirin under specialist supervision. These medications are not appropriate for everyone and should not be started without a confirmed diagnosis and medical guidance. In unexplained recurrent miscarriage, doctors may focus on close early pregnancy monitoring, individualized luteal support when appropriate and avoiding unproven therapies unless there is a clear indication.

In IVF planning, the team considers ovarian stimulation protocol, sperm preparation, fertilization method, embryo culture, genetic testing, embryo transfer timing and endometrial preparation. A single euploid embryo transfer may be recommended in many cases to reduce the risks of multiple pregnancy. If previous IVF cycles produced few embryos, the risks and benefits of PGT-A should be discussed carefully because testing may not help every patient.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat recurrent miscarriage and infertility for international patients, including coordinated fertility, genetics, endocrinology and maternal-fetal medicine input when needed. Patients may also benefit from a broader infertility evaluation if conception has been delayed or if several treatment attempts have not led to an ongoing pregnancy.

Prevention, Self-Care and When to See a Doctor

Not all miscarriages can be prevented, and patients should be reassured that most losses are not caused by normal daily activities, moderate exercise, intercourse or emotional stress. Self-care before conception can still support overall pregnancy health. This includes taking folic acid or a prenatal vitamin as advised, stopping smoking, avoiding alcohol and recreational drugs, reviewing medications with a doctor, maintaining a healthy weight and managing chronic conditions.

Couples should seek medical advice after two miscarriages, after any second-trimester loss, after miscarriage with heavy bleeding or fever, or after a loss following IVF with a tested embryo. Earlier evaluation is also reasonable for patients over 35, those with known uterine or endocrine conditions, or anyone who feels emotionally ready to understand possible causes.

Emotional support is an important part of care. Recurrent miscarriage can bring grief, anxiety and uncertainty, especially when tests are normal. Counseling, support groups and clear follow-up plans can help patients feel more informed and less alone while they decide whether to try naturally, pursue IVF, use embryo testing or consider other family-building options.

Frequently asked questions

When should testing begin after miscarriages?

Many specialists begin evaluation after two pregnancy losses, especially if the patient is over 35 or the losses were documented by ultrasound or pathology. Some guidelines and clinics may use different thresholds. A personalized discussion with a fertility specialist can help decide when testing is appropriate.

Can IVF prevent recurrent miscarriage?

IVF can help in selected cases, particularly when embryo chromosome problems, infertility or a known genetic rearrangement are involved. However, IVF cannot prevent every miscarriage because losses can also be related to uterine, hormonal, immune or medical factors. A full evaluation is important before deciding whether IVF is the best next step.

What is PGT-A and who may benefit from it?

PGT-A is preimplantation genetic testing for aneuploidy, which screens embryos for missing or extra chromosomes before transfer. It may be useful for some patients with recurrent losses related to chromosomal errors or for certain older patients. Its benefits depend on age, embryo number, prior results and the overall fertility plan.

Does a normal PGT-A result guarantee a healthy pregnancy?

No. A euploid or chromosomally normal PGT-A result may improve embryo selection, but it does not guarantee implantation, prevent all miscarriages or rule out every genetic or pregnancy complication. Ongoing prenatal care and, when indicated, prenatal screening or diagnostic testing are still needed.

What tests are commonly done for recurrent pregnancy loss?

Common tests include uterine cavity imaging, thyroid and diabetes screening, antiphospholipid antibody testing and parental chromosome testing in selected cases. Doctors may also review ovarian reserve, semen analysis, previous embryo or miscarriage tissue results and medical history. Testing should be tailored rather than automatically using every available panel.

What if all recurrent miscarriage tests are normal?

It is common for no single cause to be found, which can be frustrating but does not mean there is no chance of a successful pregnancy. Treatment may focus on optimizing health, careful timing, early monitoring and discussing whether IVF with or without PGT-A is reasonable. Emotional support and follow-up planning are also important parts of care.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.